APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lansoprazole

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lansoprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchLansoprazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Lansoprazole Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Lansoprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lansoprazole Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Lansoprazole Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Lansoprazole market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Suzhou YUSHI Pharmaceutical Co., Sandoz, Nang Kuang Pharmaceutical, Mylan, Luoxin Biotechnology, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lansoprazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lansoprazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lansoprazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lansoprazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Lansoprazole Segment by Company

Takeda Pharmaceutical

Teva Pharms

Suzhou YUSHI Pharmaceutical Co.

Sandoz

Nang Kuang Pharmaceutical

Mylan

Luoxin Biotechnology

Pfizer

GSK

Changzhou Siyao Pharmaceuticals

Beijing Honglin Pharma.

Youcare Pharmaceutical Group

Taj Pharma

Sun Pharmaceutical Industries

Lepu Pharmaceuticals

Krka

HOPE PHARMA

Dr. Reddy's

Cisen Pharmaceutical

Lansoprazole Segment by Type

Injection

Tablets

Capsules

Lansoprazole Segment by Application

Male

Female

Lansoprazole Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lansoprazole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lansoprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lansoprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lansoprazole Industry Trends Table 2. Lansoprazole Industry Drivers Table 3. Lansoprazole Industry Opportunities and Challenges Table 4. Lansoprazole Industry Restraints Table 5. Global Lansoprazole Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lansoprazole Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lansoprazole Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Lansoprazole Sales Market Share by Manufacturers Table 9. Global Lansoprazole Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lansoprazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lansoprazole Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lansoprazole Manufacturers, Product Type & Application Table 13. Global Lansoprazole Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lansoprazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Tablets Table 18. Major Manufacturers of Capsules Table 19. Global Lansoprazole Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Lansoprazole Sales by Type (2021-2026) & (W Units) Table 21. Global Lansoprazole Sales by Type (2027-2032) & (W Units) Table 22. Global Lansoprazole Sales Market Share by Type (2021-2026) Table 23. Global Lansoprazole Sales Market Share by Type (2027-2032) Table 24. Global Lansoprazole Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Lansoprazole Revenue by Type (2021-2026) & (W Units) Table 26. Global Lansoprazole Revenue by Type (2027-2032) & (W Units) Table 27. Global Lansoprazole Revenue Market Share by Type (2021-2026) Table 28. Global Lansoprazole Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Male Table 30. Major Manufacturers of Female Table 31. Global Lansoprazole Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Lansoprazole Sales by Application (2021-2026) & (W Units) Table 33. Global Lansoprazole Sales by Application (2027-2032) & (W Units) Table 34. Global Lansoprazole Sales Market Share by Application (2021-2026) Table 35. Global Lansoprazole Sales Market Share by Application (2027-2032) Table 36. Global Lansoprazole Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Lansoprazole Revenue by Application (2021-2026) & (W Units) Table 38. Global Lansoprazole Revenue by Application (2027-2032) & (W Units) Table 39. Global Lansoprazole Revenue Market Share by Application (2021-2026) Table 40. Global Lansoprazole Revenue Market Share by Application (2027-2032) Table 41. Global Lansoprazole Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Lansoprazole Sales by Region (2021-2026) & (W Units) Table 43. Global Lansoprazole Sales Market Share by Region (2021-2026) Table 44. Global Lansoprazole Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Lansoprazole Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Lansoprazole Sales by Country (2021-2026) & (W Units) Table 48. North America Lansoprazole Sales by Country (2027-2032) & (W Units) Table 49. Europe Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Lansoprazole Sales by Country (2021-2026) & (W Units) Table 51. Europe Lansoprazole Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Lansoprazole Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Lansoprazole Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Lansoprazole Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Lansoprazole Sales by Country (2027-2032) & (W Units) Table 58. Global Lansoprazole Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lansoprazole Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lansoprazole Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lansoprazole Revenue Market Share by Region (2021-2026) Table 62. Global Lansoprazole Revenue Market Share by Region (2027-2032) Table 63. Takeda Pharmaceutical Company Information Table 64. Takeda Pharmaceutical Business Overview Table 65. Takeda Pharmaceutical Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Lansoprazole Product Portfolio Table 67. Takeda Pharmaceutical Recent Development Table 68. Teva Pharms Company Information Table 69. Teva Pharms Business Overview Table 70. Teva Pharms Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Pharms Lansoprazole Product Portfolio Table 72. Teva Pharms Recent Development Table 73. Suzhou YUSHI Pharmaceutical Co. Company Information Table 74. Suzhou YUSHI Pharmaceutical Co. Business Overview Table 75. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio Table 77. Suzhou YUSHI Pharmaceutical Co. Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sandoz Lansoprazole Product Portfolio Table 82. Sandoz Recent Development Table 83. Nang Kuang Pharmaceutical Company Information Table 84. Nang Kuang Pharmaceutical Business Overview Table 85. Nang Kuang Pharmaceutical Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Nang Kuang Pharmaceutical Lansoprazole Product Portfolio Table 87. Nang Kuang Pharmaceutical Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan Lansoprazole Product Portfolio Table 92. Mylan Recent Development Table 93. Luoxin Biotechnology Company Information Table 94. Luoxin Biotechnology Business Overview Table 95. Luoxin Biotechnology Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Luoxin Biotechnology Lansoprazole Product Portfolio Table 97. Luoxin Biotechnology Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer Lansoprazole Product Portfolio Table 102. Pfizer Recent Development Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. GSK Lansoprazole Product Portfolio Table 107. GSK Recent Development Table 108. Changzhou Siyao Pharmaceuticals Company Information Table 109. Changzhou Siyao Pharmaceuticals Business Overview Table 110. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio Table 112. Changzhou Siyao Pharmaceuticals Recent Development Table 113. Beijing Honglin Pharma. Company Information Table 114. Beijing Honglin Pharma. Business Overview Table 115. Beijing Honglin Pharma. Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Beijing Honglin Pharma. Lansoprazole Product Portfolio Table 117. Beijing Honglin Pharma. Recent Development Table 118. Youcare Pharmaceutical Group Company Information Table 119. Youcare Pharmaceutical Group Business Overview Table 120. Youcare Pharmaceutical Group Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Youcare Pharmaceutical Group Lansoprazole Product Portfolio Table 122. Youcare Pharmaceutical Group Recent Development Table 123. Taj Pharma Company Information Table 124. Taj Pharma Business Overview Table 125. Taj Pharma Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Taj Pharma Lansoprazole Product Portfolio Table 127. Taj Pharma Recent Development Table 128. Sun Pharmaceutical Industries Company Information Table 129. Sun Pharmaceutical Industries Business Overview Table 130. Sun Pharmaceutical Industries Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Sun Pharmaceutical Industries Lansoprazole Product Portfolio Table 132. Sun Pharmaceutical Industries Recent Development Table 133. Lepu Pharmaceuticals Company Information Table 134. Lepu Pharmaceuticals Business Overview Table 135. Lepu Pharmaceuticals Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Lepu Pharmaceuticals Lansoprazole Product Portfolio Table 137. Lepu Pharmaceuticals Recent Development Table 138. Krka Company Information Table 139. Krka Business Overview Table 140. Krka Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Krka Lansoprazole Product Portfolio Table 142. Krka Recent Development Table 143. HOPE PHARMA Company Information Table 144. HOPE PHARMA Business Overview Table 145. HOPE PHARMA Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. HOPE PHARMA Lansoprazole Product Portfolio Table 147. HOPE PHARMA Recent Development Table 148. Dr. Reddy's Company Information Table 149. Dr. Reddy's Business Overview Table 150. Dr. Reddy's Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Dr. Reddy's Lansoprazole Product Portfolio Table 152. Dr. Reddy's Recent Development Table 153. Cisen Pharmaceutical Company Information Table 154. Cisen Pharmaceutical Business Overview Table 155. Cisen Pharmaceutical Lansoprazole Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Cisen Pharmaceutical Lansoprazole Product Portfolio Table 157. Cisen Pharmaceutical Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Lansoprazole Distributors List Table 161. Lansoprazole Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Lansoprazole Product Image Figure 2. Global Lansoprazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lansoprazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Lansoprazole Sales (2021-2032) & (W Units) Figure 5. Global Lansoprazole Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lansoprazole Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Lansoprazole Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Lansoprazole Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Lansoprazole Sales Market Share by Type (2021-2032) Figure 14. Global Lansoprazole Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Lansoprazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Lansoprazole Revenue Market Share by Type (2021-2032) Figure 17. Male Image Figure 18. Female Image Figure 19. Global Lansoprazole Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Lansoprazole Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lansoprazole Sales Market Share by Application (2021-2032) Figure 22. Global Lansoprazole Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Lansoprazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lansoprazole Revenue Market Share by Application (2021-2032) Figure 25. North America Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Lansoprazole Sales Market Share by Country (2021-2032) Figure 27. U.S. Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Lansoprazole Sales Market Share by Country (2021-2032) Figure 32. Germany Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Lansoprazole Sales Market Share by Country (2021-2032) Figure 39. China Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Lansoprazole Sales Market Share by Country (2021-2032) Figure 47. Brazil Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Lansoprazole Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Lansoprazole Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lansoprazole Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lansoprazole Revenue (2021-2032) & (US$ Million) Figure 58. North America Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lansoprazole Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lansoprazole Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lansoprazole Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lansoprazole Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lansoprazole Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
  • Capsules
Applications
  • Male
  • Female
Companies covered
  • Takeda Pharmaceutical
  • Teva Pharms
  • Suzhou YUSHI Pharmaceutical Co.
  • Sandoz
  • Nang Kuang Pharmaceutical
  • Mylan
  • Luoxin Biotechnology
  • Pfizer
  • GSK
  • Changzhou Siyao Pharmaceuticals
  • Beijing Honglin Pharma.
  • Youcare Pharmaceutical Group
  • Taj Pharma
  • Sun Pharmaceutical Industries
  • Lepu Pharmaceuticals
  • Krka
  • HOPE PHARMA
  • Dr. Reddy's
  • Cisen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lansoprazole Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lansoprazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lansoprazole Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lansoprazole Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lansoprazole Market Dynamics
  1. 2.1 Lansoprazole Industry Trends
  2. 2.2 Lansoprazole Industry Drivers
  3. 2.3 Lansoprazole Industry Opportunities and Challenges
  4. 2.4 Lansoprazole Industry Restraints
3 Lansoprazole Market by Manufacturers
  1. 3.1 Global Lansoprazole Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lansoprazole Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lansoprazole Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lansoprazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lansoprazole Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lansoprazole Manufacturers, Product Type & Application
  7. 3.7 Global Lansoprazole Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lansoprazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lansoprazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lansoprazole Tier 1, Tier 2, and Tier 3
4 Lansoprazole Market by Type
  1. 4.1 Lansoprazole Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablets
  4. 4.1.3 Capsules
  5. 4.2 Global Lansoprazole Sales by Type
  6. 4.2.1 Global Lansoprazole Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lansoprazole Sales by Type (2021-2032)
  8. 4.2.3 Global Lansoprazole Sales Market Share by Type (2021-2032)
  9. 4.3 Global Lansoprazole Revenue by Type
  10. 4.3.1 Global Lansoprazole Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Lansoprazole Revenue by Type (2021-2032)
  12. 4.3.3 Global Lansoprazole Revenue Market Share by Type (2021-2032)
5 Lansoprazole Market by Application
  1. 5.1 Lansoprazole Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Lansoprazole Sales by Application
  5. 5.2.1 Global Lansoprazole Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lansoprazole Sales by Application (2021-2032)
  7. 5.2.3 Global Lansoprazole Sales Market Share by Application (2021-2032)
  8. 5.3 Global Lansoprazole Revenue by Application
  9. 5.3.1 Global Lansoprazole Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lansoprazole Revenue by Application (2021-2032)
  11. 5.3.3 Global Lansoprazole Revenue Market Share by Application (2021-2032)
6 Global Lansoprazole Sales by Region
  1. 6.1 Global Lansoprazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lansoprazole Sales by Region (2021-2032)
  3. 6.2.1 Global Lansoprazole Sales by Region (2021-2026)
  4. 6.2.2 Global Lansoprazole Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lansoprazole Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lansoprazole Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lansoprazole Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lansoprazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lansoprazole Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lansoprazole Revenue by Region
  1. 7.1 Global Lansoprazole Revenue by Region
  2. 7.1.1 Global Lansoprazole Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lansoprazole Revenue by Region (2021-2026)
  4. 7.1.3 Global Lansoprazole Revenue by Region (2027-2032)
  5. 7.1.4 Global Lansoprazole Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lansoprazole Revenue (2021-2032)
  8. 7.2.2 North America Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lansoprazole Revenue (2021-2032)
  11. 7.3.2 Europe Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lansoprazole Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lansoprazole Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lansoprazole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical
  2. 8.1.1 Takeda Pharmaceutical Company Information
  3. 8.1.2 Takeda Pharmaceutical Business Overview
  4. 8.1.3 Takeda Pharmaceutical Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Recent Developments
  7. 8.2 Teva Pharms
  8. 8.2.1 Teva Pharms Company Information
  9. 8.2.2 Teva Pharms Business Overview
  10. 8.2.3 Teva Pharms Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharms Lansoprazole Product Portfolio
  12. 8.2.5 Teva Pharms Recent Developments
  13. 8.3 Suzhou YUSHI Pharmaceutical Co.
  14. 8.3.1 Suzhou YUSHI Pharmaceutical Co. Company Information
  15. 8.3.2 Suzhou YUSHI Pharmaceutical Co. Business Overview
  16. 8.3.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
  18. 8.3.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Lansoprazole Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Nang Kuang Pharmaceutical
  26. 8.5.1 Nang Kuang Pharmaceutical Company Information
  27. 8.5.2 Nang Kuang Pharmaceutical Business Overview
  28. 8.5.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
  30. 8.5.5 Nang Kuang Pharmaceutical Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Lansoprazole Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Luoxin Biotechnology
  38. 8.7.1 Luoxin Biotechnology Company Information
  39. 8.7.2 Luoxin Biotechnology Business Overview
  40. 8.7.3 Luoxin Biotechnology Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Luoxin Biotechnology Lansoprazole Product Portfolio
  42. 8.7.5 Luoxin Biotechnology Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Lansoprazole Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 GSK
  50. 8.9.1 GSK Company Information
  51. 8.9.2 GSK Business Overview
  52. 8.9.3 GSK Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GSK Lansoprazole Product Portfolio
  54. 8.9.5 GSK Recent Developments
  55. 8.10 Changzhou Siyao Pharmaceuticals
  56. 8.10.1 Changzhou Siyao Pharmaceuticals Company Information
  57. 8.10.2 Changzhou Siyao Pharmaceuticals Business Overview
  58. 8.10.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
  60. 8.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
  61. 8.11 Beijing Honglin Pharma.
  62. 8.11.1 Beijing Honglin Pharma. Company Information
  63. 8.11.2 Beijing Honglin Pharma. Business Overview
  64. 8.11.3 Beijing Honglin Pharma. Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
  66. 8.11.5 Beijing Honglin Pharma. Recent Developments
  67. 8.12 Youcare Pharmaceutical Group
  68. 8.12.1 Youcare Pharmaceutical Group Company Information
  69. 8.12.2 Youcare Pharmaceutical Group Business Overview
  70. 8.12.3 Youcare Pharmaceutical Group Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
  72. 8.12.5 Youcare Pharmaceutical Group Recent Developments
  73. 8.13 Taj Pharma
  74. 8.13.1 Taj Pharma Company Information
  75. 8.13.2 Taj Pharma Business Overview
  76. 8.13.3 Taj Pharma Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Taj Pharma Lansoprazole Product Portfolio
  78. 8.13.5 Taj Pharma Recent Developments
  79. 8.14 Sun Pharmaceutical Industries
  80. 8.14.1 Sun Pharmaceutical Industries Company Information
  81. 8.14.2 Sun Pharmaceutical Industries Business Overview
  82. 8.14.3 Sun Pharmaceutical Industries Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
  84. 8.14.5 Sun Pharmaceutical Industries Recent Developments
  85. 8.15 Lepu Pharmaceuticals
  86. 8.15.1 Lepu Pharmaceuticals Company Information
  87. 8.15.2 Lepu Pharmaceuticals Business Overview
  88. 8.15.3 Lepu Pharmaceuticals Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
  90. 8.15.5 Lepu Pharmaceuticals Recent Developments
  91. 8.16 Krka
  92. 8.16.1 Krka Company Information
  93. 8.16.2 Krka Business Overview
  94. 8.16.3 Krka Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Krka Lansoprazole Product Portfolio
  96. 8.16.5 Krka Recent Developments
  97. 8.17 HOPE PHARMA
  98. 8.17.1 HOPE PHARMA Company Information
  99. 8.17.2 HOPE PHARMA Business Overview
  100. 8.17.3 HOPE PHARMA Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 HOPE PHARMA Lansoprazole Product Portfolio
  102. 8.17.5 HOPE PHARMA Recent Developments
  103. 8.18 Dr. Reddy's
  104. 8.18.1 Dr. Reddy's Company Information
  105. 8.18.2 Dr. Reddy's Business Overview
  106. 8.18.3 Dr. Reddy's Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy's Lansoprazole Product Portfolio
  108. 8.18.5 Dr. Reddy's Recent Developments
  109. 8.19 Cisen Pharmaceutical
  110. 8.19.1 Cisen Pharmaceutical Company Information
  111. 8.19.2 Cisen Pharmaceutical Business Overview
  112. 8.19.3 Cisen Pharmaceutical Lansoprazole Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
  114. 8.19.5 Cisen Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lansoprazole Value Chain Analysis
  2. 9.1.1 Lansoprazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lansoprazole Production Mode & Process
  6. 9.2 Lansoprazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lansoprazole Distributors
  9. 9.2.3 Lansoprazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst